Fetal and early neonatal interleukin-6 response

Cytokine

Volumn 76, Issue 1, 2015, Pages 1-12

  Chiesa, Claudio ^a   Pacifico, Lucia ^b   Natale, Fabio ^b   Hofer, Nora ^c   Osborn, John F ^d   Resch, Bernhard ^c  

^a INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Diagnostic accuracy; Early onset neonatal sepsis; Fetal inflammatory response syndrome; Interleukin 6; Reference intervals

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; STEROID; TOLL LIKE RECEPTOR; IL6 PROTEIN, HUMAN;

AMNIOCENTESIS; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; BIRTH WEIGHT; BLOOD CULTURE; BRAIN INJURY; CELL ACTIVATION; CELL PROLIFERATION; CEREBROSPINAL FLUID ANALYSIS; CHORIOAMNIONITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; GESTATIONAL AGE; HUMAN; LONGITUDINAL STUDY; MACROPHAGE; MONOCYTE; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN SEPSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINATAL PERIOD; PHYSIOLOGICAL STRESS; PLEIOTROPY; PNEUMONIA; PREDICTIVE VALUE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT; WHITE MATTER INJURY; BLOOD; FEMALE; FETUS; FETUS BLOOD; IMMUNOLOGY; LEUKOENCEPHALOPATHIES; MEASUREMENT ACCURACY; PHYSIOLOGY; PREGNANCY; PREMATURITY; REFERENCE VALUE; SEPSIS;

DATA ACCURACY; FEMALE; FETAL BLOOD; FETUS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTERLEUKIN-6; LEUKOENCEPHALOPATHIES; PREGNANCY; PREMATURE BIRTH; REFERENCE VALUES; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84941746624     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.03.015     Document Type: Review

References (131)

1. Chiesa C., Panero A., Osborn J.F., Simonetti A.F., Pacifico L. Diagnosis of neonatal sepsis: a clinical and laboratory challenge. Clin Chem 2004, 50:279-287.
2. Kurdowska A., Krupa A. Blockade of interleukin-6 in murine sepsis revisited: is there an indication for a new therapy in human patients?. Crit Care Med 2011, 39:1582-1583.
3. Ulevitch R.J. Therapeutics targeting the innate immune system. Nature Rev Immunol 2004, 4:512-520.
4. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
5. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
6. Tanaka T., Kishimoto T. Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int J Biol Sci 2012, 8:1227-1236.
7. Mihara M., Hashizume M., Yoshida H., Suzuki M., Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci 2012, 122:143-159.
8. Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci 2012, 8:1237-1247.
9. Kallen K.J. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 2002, 1592:323-343.
10. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989, 169:333-338.
11. Jones S.A., Scheller J., Rose-John S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 2011, 121:3375-3383.
12. Rose-John S., Scheller J., Elson G., Jones S.A. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 2006, 80:227-236.
13. Scheller J., Rose-John S. Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol 2006, 195:173-183.
14. Peters M., Jacobs S., Ehlers M., Vollmer P., Müllberg J., Wolf E., et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med 1996, 183:1399-1406.
15. Montero-Julian F.A. The soluble IL-6 receptors: serum levels and biological function. Cell Mol Biol 2001, 47:583-597.
16. Mitsuyama K., Toyonaga A., Sasaki E., Ishida O., Ikeda H., Tsuruta O., et al. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 1995, 36:45-49.
17. Gaillard J.P., Bataille R., Brailly H., Zuber C., Yasukawa K., Attal M., et al. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol 1993, 23:820-824.
18. Rose-John S., Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 1994, 300(Pt 2):281-290.
19. Jones S.A., Horiuchi S., Topley N., Yamamoto N., Fuller G.M. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 2001, 15:43-58.
20. Wolf J., Rose-John S., Garbers C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine 2014, 70:11-20.
21. Garbers C., Thaiss W., Jones G.W., Waetzig G.H., Lorenzen I., Guilhot F., et al. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. J Biol Chem 2011, 286:42959-42970.
22. Klouche M., Bhakdi S., Hemmes M., Rose-John S. Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. J Immunol 1999, 163:4583-4589.
23. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6:315-325.
24. Hurst S.M., Wilkinson T.S., McLoughlin R.M., Jones S., Horiuchi S., Yamamoto N., et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001, 14:705-714.
25. Meszaros A.J., Reichner J.S., Albina J.E. Macrophage-induced neutrophil apoptosis. J Immunol 2000, 165:435-441.
26. Teague T.K., Marrack P., Kappler J.W., Vella A.T. IL-6 rescues resting mouse T cells from apoptosis. J Immunol 1997, 158:5791-5796.
27. Peters M., Schirmacher P., Goldschmitt J., Odenthal M., Peschel C., Fattori E., et al. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J Exp Med 1997, 185:755-766.
28. Peters M., Müller A.M., Rose-John S. Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood 1998, 92:3495-3504.
29. Jostock T., Müllberg J., Ozbek S., Atreya R., Blinn G., Voltz N., et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 2001, 268:160-167.
30. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011, 1813:878-888.
31. Wakabayashi A., Sawada K., Nakayama M., Toda A., Kimoto A., Mabuchi S., et al. Targeting interleukin-6 receptor inhibits preterm delivery induced by inflammation. Mol Hum Reprod 2013, 19:718-726.
32. Romero R., Espinoza J., Kusanovic J.P., Gotsch F., Hassan S., Erez O., et al. The preterm parturition syndrome. BJOG 2006, 113(Suppl 3):S17-42.
33. Goldenberg R.L., Culhane J.F., Iams J.D., Romero R. Epidemiology and causes of preterm birth. Lancet 2008, 371:75-84.
34. Hagberg H., Mallard C., Jacobsson B. Role of cytokines in preterm labour and brain injury. BJOG 2005, 112(Suppl 1). S16-8.
35. El-Bastawissi A.Y., Williams M.A., Riley D.E., Hitti J., Krieger J.N. Amniotic fluid interleukin-6 and preterm delivery: a review. Obstet Gynecol 2000, 95(6 Pt 2):1056-1064.
36. Harirah H., Donia S.E., Hsu C.D. Amniotic fluid matrix metalloproteinase-9 and interleukin-6 in predicting intra-amniotic infection. Obstet Gynecol 2002, 99:80-84.
37. Krupa F.G., Faltin D., Cecatti J.G., Surita F.G., Souza J.P. Predictors of preterm birth. Int J Gynaecol Obstet 2006, 94:5-11.
38. Lee S.Y., Buhimschi I.A., Dulay A.T., Ali U.A., Zhao G., Abdel-Razeq S.S., et al. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes. J Immunol 2011, 186:3226-3236.
39. Thomakos N., Daskalakis G., Papapanagiotou A., Papantoniou N., Mesogitis S., Antsaklis A. Amniotic fluid interleukin-6 and tumor necrosis factor-alpha at mid-trimester genetic amniocentesis: relationship to intra-amniotic microbial invasion and preterm delivery. Eur J Obstet Gynecol Reprod Biol 2010, 148:147-151.
40. Vrachnis N., Karavolos S., Iliodromiti Z., Sifakis S., Siristatidis C., Mastorakos G., et al. Review: impact of mediators present in amniotic fluid on preterm labour. In Vivo 2012, 26:799-812.
41. Gervasi M.T., Romero R., Bracalente G., Erez O., Dong Z., Hassan S.S., et al. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med 2012, 40:329-343.
42. Taylor B.D., Holzman C.B., Fichorova R.N., Tian Y., Jones N.M., Fu W., et al. Inflammation biomarkers in vaginal fluid and preterm delivery. Hum Reprod 2013, 28:942-952.
43. Keelan J.A., Marvin K.W., Sato T.A., Coleman M., McCowan L.M., Mitchell M.D. Cytokine abundance in placental tissues: evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am J Obstet Gynecol 1999, 181:1530-1536.
44. Young A., Thomson A.J., Ledingham M., Jordan F., Greer I.A., Norman J.E. Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol Reprod 2002, 66:445-449.
45. Keelan J.A., Blumenstein M., Helliwell R.J., Sato T.A., Marvin K.W., Mitchell M.D. Cytokines, prostaglandins and parturition-a review. Placenta 2003, 24(Suppl A):S33-46.
46. Gomez-Lopez N., Laresgoiti-Servitje E., Olson D.M., Estrada-Gutiérrez G., Vadillo-Ortega F. The role of chemokines in term and premature rupture of the fetal membranes: a review. Biol Reprod 2010, 82:809-814.
47. Geer L.A., Pycke B.F., Sherer D.M., Abulafia O., Halden R.U. Use of amniotic fluid for determining pregnancies at risk of preterm birth and for studying diseases of potential environmental etiology. Environ Res 2015, 136:470-481.
48. Romero R., Mazor M., Wu Y.K., Sirtori M., Oyarzun E., Mitchell M.D., et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988, 12:262-279.
49. Romero R., Baumann P., Gomez R., Salafia C., Rittenhouse L., Barberio D., et al. The relationship between spontaneous rupture of membranes, labor, and microbial invasion of the amniotic cavity and amniotic fluid concentrations of prostaglandins and thromboxane B2 in term pregnancy. Am J Obstet Gynecol 1993, 168(6 Pt 1):1654-1664.
50. Lockwood C.J., Murk W.K., Kayisli U.A., Buchwalder L.F., Huang S.J., Arcuri F., et al. Regulation of interleukin-6 expression in human decidual cells and its potential role in chorioamnionitis. Am J Pathol 2010, 177:1755-1764.
51. Keelan J.A., Sato T., Mitchell M.D. Interleukin (IL)-6 and IL-8 production by human amnion: regulation by cytokines, growth factors, glucocorticoids, phorbol esters, and bacterial lipopolysaccharide. Biol Reprod 1997, 57:1438-1444.
52. Romero R., Gomez R., Ghezzi F., Yoon B.H., Mazor M., Edwin S.S., et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998, 179:186-193.
53. Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., Berry S.M. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998, 179:194-202.
54. Gotsch F., Romero R., Kusanovic J.P., Mazaki-Tovi S., Pineles B.L., Erez O., et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007, 50:652-683.
55. Hofer N., Kothari R., Morris N., Müller W., Resch B. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol 2013, 209. 542.e1-11.
56. Buhimschi C.S., Dulay A.T., Abdel-Razeq S., Zhao G., Lee S., Hodgson E.J., et al. Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. BJOG 2009, 116:257-267.
57. Buhimschi C.S., Buhimschi I.A., Abdel-Razeq S., Rosenberg V.A., Thung S.F., Zhao G., et al. Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr Res 2007, 61:318-324.
58. Buhimschi I.A., Zambrano E., Pettker C.M., Bahtiyar M.O., Paidas M., Rosenberg V.A., et al. Using proteomic analysis of the human amniotic fluid to identify histologic chorioamnionitis. Obstet Gynecol 2008, 111:403-412.
59. Chiesa C., Signore F., Assumma M., Buffone E., Tramontozzi P., Osborn J.F., et al. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders. Clin Chem 2001, 47:1016-1022.
60. Marchini G., Berggren V., Djilali-Merzoug R., Hansson L.-O. The birth process initiates an acute phase reaction in the fetus-newborn infant. Acta Paediatr 2000, 89:1082-1086.
61. Labenne M., Lizard G., Ferdynus C., Montange T., Iacobelli S., Bonsante F., et al. A clinic-biological score for diagnosing early-onset neonatal infection in critically ill preterm infants. Pediatr Crit Care Med 2011, 12:203-209.
62. Newcombe RG, Altman DG. Proportions and their differences. In: Altman DG, Machin D, Bryant TN, Gardner MJ, editors. Statistics with Confidence. BMJ Books, 2nd ed. 2005, p. 45-56. [chapter 6].
63. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003, 49:1-6.
64. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003, 49:7-18.
65. Korevaar D.A., van Enst W.A., Spijker R., Bossuyt P.M., Hooft L. Reporting quality of diagnostic accuracy studies: a systematic review and meta-analysis of investigations on adherence to STARD. Evid Based Med 2014, 19:47-54.
66. Lijmer J.G., Mol B.W., Heisterkamp S., Bonsel G.J., Prins M.H., van der Meulen J.H., et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999, 282:1061-1066.
67. Whiting P., Rutjes A.W., Reitsma J.B., Glas A.S., Bossuyt P.M., Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 2004, 140:189-202.
68. Rutjes A.W., Reitsma J.B., Di Nisio M., Smidt N., van Rijn J.C., Bossuyt P.M. Evidence of bias and variation in diagnostic accuracy studies. CMAJ 2006, 174:469-476.
69. Wilczynski N.L. Quality of reporting of diagnostic accuracy studies: no change since STARD statement publication-before-and-after study. Radiology 2008, 248:817-823.
70. Cobo T., Kacerovsky M., Andrys C., Drahosova M., Musilova I., Hornychova H., et al. Umbilical cord blood IL-6 as predictor of early-onset neonatal sepsis in women with preterm prelabour rupture of membranes. PLoS One 2013, 8:e69341.
71. Smulian J.C., Bhandari V., Campbell W.A., Rodis J.F., Vintzileos A.M. Value of umbilical artery and vein levels of interleukin-6 and soluble intracellular adhesion molecule-1 as predictors of neonatal hematologic indices and suspected early sepsis. J Matern Fetal Med 1997, 6:254-259.
72. Lehrnbecher T., Schrod L., Kraus D., Roos T., Martius J., von Stockhausen H.B. Interleukin-6 and soluble interleukin-6 receptor in cord blood in the diagnosis of early onset sepsis in neonates. Acta Paediatr 1995, 84:806-808.
73. Messer J., Eyer D., Donato L., Gallati H., Matis J., Simeoni U. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr 1996, 129:574-580.
74. Panero A., Pacifico L., Rossi N., Mancuso G., Stegagno M., Chiesa C. Interleukin 6 in neonates with early and late onset infection. Pediatr Infect Dis J 1997, 16:370-375.
75. Smulian J.C., Vintzileos A.M., Lai Y.L., Santiago J., Shen-Schwarz S., Campbell W.A. Maternal chorioamnionitis and umbilical vein interleukin-6 levels for identifying early neonatal sepsis. J Matern Fetal Med 1999, 8:88-94.
76. Kashlan F., Smulian J., Shen-Schwarz S., Anwar M., Hiatt M., Hegyi T. Umbilical vein interleukin 6 and tumor necrosis factor alpha plasma concentrations in the very preterm infant. Pediatr Infect Dis J 2000, 19:238-243.
77. Døllner H., Vatten L., Linnebo I., Zanussi G.F., Laerdal A., Austgulen R. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol Neonate 2001, 80:41-47.
78. Martin H., Olander B., Norman M. Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-alpha in the diagnosis of early-onset neonatal sepsis. Pediatrics 2001, 108:e61.
79. Santana C., Guindeo M.C., González G., García-Muñoz F., Saavedra P., Doménech E. Cord blood levels of cytokines as predictors of early neonatal sepsis. Acta Paediatr 2001, 90:1176-1181.
80. Krueger M., Nauck M.S., Sang S., Hentschel R., Wieland H., Berner R. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biol Neonate 2001, 80:118-123.
81. Chiesa C., Pellegrini G., Panero A., Osborn J.F., Signore F., Assumma M., et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003, 49:60-68.
82. Resch B., Gusenleitner W., Müller W.D. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr 2003, 92:243-245.
83. Bender L., Thaarup J., Varming K., Krarup H., Ellermann-Eriksen S., Ebbesen F. Early and late markers for the detection of early-onset neonatal sepsis. Dan Med Bull 2008, 55:219-223.
84. Rego M.A., Martinez F.E., Elias J., Mussi-Pinhata M.M. Diagnostic value of interleukin-6 and C-reactive protein on early onset bacterial infection in preterm neonates with respiratory distress. J Perinat Med 2010, 38:527-533.
85. Abdollahi A., Shoar S., Nayyeri F., Shariat M. Diagnostic value of simultaneous measurement of procalcitonin, interleukin-6 and hs-CRP in prediction of early-onset neonatal sepsis. Mediterr J Hematol Infect Dis 2012, 4:e2012028.
86. Cernada M., Badía N., Modesto V., Alonso R., Mejías A., Golombek S., et al. Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis. Acta Paediatr 2012, 101:203-207.
87. Steinberger E., Hofer N., Resch B. Cord blood procalcitonin and interleukin-6 are highly sensitive and specific in the prediction of early-onset sepsis in preterm infants. Scand J Clin Lab Invest 2014, 74:432-436.
88. Rutjes A.W., Reitsma J.B., Vandenbroucke J.P., Glas A.S., Bossuyt P.M. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem 2005, 51:1335-1341.
89. Philbrick J.T., Horwitz R.I., Feinstein A.R., Langou R.A., Chandler J.P. The limited spectrum of patients studied in exercise test research. Analyzing the tip of the iceberg. JAMA 1982, 248:2467-2470.
90. Ransohoff D.F., Feinstein A.R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978, 299:926-930.
91. Worster A., Carpenter C. Incorporation bias in studies of diagnostic tests: how to avoid being biased about bias. CJEM 2008, 10:174-175.
92. Harper R., Reeves B. Reporting of precision of estimates for diagnostic accuracy: a review. BMJ 1999, 318:1322-1323.
93. Weeks J.W., Reynolds L., Taylor D., Lewis J., Wan T., Gall S.A. Umbilical cord blood interleukin-6 levels and neonatal morbidity. Obstet Gynecol 1997, 90:815-818.
94. Richardson D.K., Gray J.E., McCormick M.C., Workman K., Goldmann D.A. Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care. Pediatrics 1993, 91:617-623.
95. Richardson D.K., Shah B.L., Frantz I.D., Bednarek F., Rubin L.P., McCormick M.C. Perinatal risk and severity of illness in newborns at 6 neonatal intensive care units. Am J Public Health 1999, 89:511-516.
96. Catlin E.A., Carpenter M.W., Brann B.S., Mayfield S.R., Shaul P.W., Goldstein M., et al. The Apgar score revisited: influence of gestational age. J Pediatr 1986, 109:865-868.
97. Richardson D.K., Phibbs C.S., Gray J.E., McCormick M.C., Workman-Daniels K., Goldmann D.A. Birth weight and illness severity: independent predictors of neonatal mortality. Pediatrics 1993, 91:969-975.
98. Richardson D.K., Corcoran J.D., Escobar G.J., Lee S.K. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr 2001, 138:92-100.
99. Haahr P.M., Pedersen B.K., Fomsgaard A., Tvede N., Diamant M., Klarlund K., et al. Effect of physical exercise on in vitro production of interleukin 1, interleukin 6, tumour necrosis factor-alpha, interleukin 2 and interferon-gamma. Int J Sports Med 1991, 12:223-227.
100. Chan C.J., Summers K.L., Chan N.G., Hardy D.B. Cytokines in umbilical cord blood and the impact of labor events in low-risk term pregnancies. Early Hum Dev 2013, 89:1005-1010.
101. Jokic M., Guillois B., Cauquelin B., Giroux J.D., Bessis J.L., Morello R., et al. Fetal distress increases interleukin-6 and interleukin-8 and decreases tumour necrosis factor-alpha cord blood levels in noninfected full-term neonates. BJOG 2000, 107:420-425.
102. Malamitsi-Puchner A., Protonotariou E., Boutsikou T., Makrakis E., Sarandakou A., Creatsas G., et al. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum Dev 2005, 81:387-392.
103. Rogers B.B., Alexander J.M., Head J., McIntire D., Leveno K.J. Umbilical vein interleukin-6 levels correlate with the severity of placental inflammation and gestational age. Hum Pathol 2002, 33:335-340.
104. Mestan K., Yu Y., Thorsen P., Skogstrand K., Matoba N., Liu X., et al. Cord blood biomarkers of the fetal inflammatory response. J Matern Fetal Neonatal Med 2009, 22:379-387.
105. Martín-Ancel A., García-Alix A., Pascual-Salcedo D., Cabañas F., Valcarce M. Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations. Pediatrics 1997, 100:789-794.
106. Sävman K., Blennow M., Gustafson K., Tarkowski E., Hagberg H. Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr Res 1998, 43:746-751.
107. Chiesa C., Pellegrini G., Panero A., De Luca T., Assumma M., Signore F., et al. Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. Eur J Clin Invest 2003, 33:352-358.
108. Aly H., Khashaba M.T., El-Ayouty M., El-Sayed O., Hasanein B.M. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev 2006, 28:178-182.
109. Walsh B.H., Boylan G.B., Livingstone V., Kenny L.C., Dempsey E.M., Murray D.M. Cord blood proteins and multichannel-electroencephalography in hypoxic-ischemic encephalopathy. Pediatr Crit Care Med 2013, 14:621-630.
110. Shalak L.F., Perlman J.M. Infection markers and early signs of neonatal encephalopathy in the term infant. Ment Retard Dev Disabil Res Rev 2002, 8:14-19.
111. Whitaker A.H., Feldman J.F., Van Rossem R., Schonfeld I.S., Pinto-Martin J.A., Torre C., et al. Neonatal cranial ultrasound abnormalities in low birth weight infants: relation to cognitive outcomes at six years of age. Pediatrics 1996, 98(4 Pt 1):719-729.
112. Bartha A.I., Foster-Barber A., Miller S.P., Vigneron D.B., Glidden D.V., Barkovich A.J., et al. Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome. Pediatr Res 2004, 56:960-966.
113. Dammann O., O'Shea T.M. Cytokines and perinatal brain damage. Clin Perinatol 2008, 35:643-663.
114. Volpe J.J. Cerebral white matter injury of the premature infant-more common than you think. Pediatrics 2003, 112:176-180.
115. Wood N.S., Marlow N., Costeloe K., Gibson A.T., Wilkinson A.R. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000, 343:378-384.
116. Hack M., Wilson-Costello D., Friedman H., Taylor G.H., Schluchter M., Fanaroff A.A. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000g: 1992-1995. Arch Pediatr Adolesc Med 2000, 154:725-731.
117. Volpe J.J. Postnatal sepsis, necrotizing enterocolitis, and the critical role of systemic inflammation in white matter injury in premature infants. J Pediatr 2008, 153:160-163.
118. Dammann O., Leviton A. Inflammatory brain damage in preterm newborns-dry numbers, wet lab, and causal inferences. Early Hum Dev 2004, 79:1-15.
119. Leviton A., Paneth N., Reuss M.L., Susser M., Allred E.N., Dammann O., et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res 1999, 46:566-575.
120. Dammann O., Phillips T.M., Allred E.N., O'Shea T.M., Paneth N., Van Marter L.J., et al. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine 2001, 13:234-239.
121. Yoon B.H., Park C.W., Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. BJOG 2003, 110(Suppl 20):S124-7.
122. Yoon B.H., Romero R., Park J.S., Kim M., Oh S.Y., Kim C.J., et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000, 183:1124-1129.
123. Martinez E., Figueroa R., Garry D., Visintainer P., Patel K., Verma U., et al. Elevated amniotic fluid interleukin-6 as a predictor of neonatal periventricular leukomalacia and intraventricular hemorrhage. J Matern Fetal Investig 1998, 8:101-107.
124. Kadhim H., Tabarki B., Verellen G., De Prez C., Rona A.M., Sébire G.H. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001, 56:1278-1284.
125. Haynes R.L., Baud O., Li J., Kinney H.C., Volpe J.J., Folkerth D.R. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol 2005, 15:225-233.
126. Glass H.C., Bonifacio S.L., Chau V., Glidden D., Poskitt K., Barkovich A.J., et al. Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics 2008, 122:299-305.
127. Shah D.K., Doyle L.W., Anderson P.J., Bear M., Daley A.J., Hunt R.W., et al. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J Pediatr 2008, 153:170-175.
128. Chau V., Brant R., Poskitt K.J., Tam E.W., Synnes A., Miller S.P. Postnatal infection is associated with widespread abnormalities of brain development in premature newborns. Pediatr Res 2012, 71:274-279.
129. Chau V., Poskitt K.J., McFadden D.E. Effect of chorioamnionitis on brain development and injury in premature newborns. Ann Neurol 2009, 66:155-164.
130. Adams E., Chau V., Poskitt K.J., Grunau R.E., Synnes A. Tractography-based quantitation of corticospinal tract development in premature newborns. J Pediatr 2010, 156:882-888.
131. Procianoy R.S., Silveira R.C. Association between high cytokine levels with white matter injury in preterm infants with sepsis. Pediatr Crit Care Med 2012, 13:183-187.